Cart
sales@molnova.com
SB 290157
CAS No. 259218-28-5
SB 290157( SB-290157 | SB290157 )
Catalog No. M13784 CAS No. 259218-28-5
A potent, selective nonpeptide antagonist of anaphylatoxin C3a receptor (C3aR) with IC50 of 200 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSB 290157
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective nonpeptide antagonist of anaphylatoxin C3a receptor (C3aR) with IC50 of 200 nM.
-
DescriptionA potent, selective nonpeptide antagonist of anaphylatoxin C3a receptor (C3aR) with IC50 of 200 nM; does not antagonize the C5aR or 5 other chemotactic GPCRs on human neutrophils; blocks C3a-induced C3aR internalization and C3a-induced Ca(2+) mobilization in RBL-C3aR cells and human neutrophils with IC50 of 27.7 and 28 nM, respectively; also inhibits C3a-induced Ca2+ mobilization of mouse and guinea pig C3aRS with IC50 of 7 and 12.5 nM, respectively; potently inhibits C3a-mediated ATP release from guinea pig platelets and inhibits C3a-induced potentiation of the contractile response to field stimulation of perfused rat caudal artery, demonstrates antiinflammatory activity in animal models.
-
In Vitro——
-
In Vivo——
-
SynonymsSB-290157 | SB290157
-
PathwayImmunology/Inflammation
-
TargetComplement System
-
RecptorComplement System
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number259218-28-5
-
Formula Weight412.49
-
Molecular FormulaC22H28N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN(2)-[(2,2-diphenylethoxy)acetyl]-L-arginine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ames RS, et al. J Immunol. 2001 May 15;166(10):6341-8.
2. Therien AG. J Immunol. 2005 Jun 15;174(12):7479; author reply 7479-80.
3. Ratajczak J, et al. Blood. 2004 Mar 15;103(6):2071-8.
4. Proctor LM, et al. Br J Pharmacol. 2004 Jun;142(4):756-64.
molnova catalog
related products
-
Vesencumab
Vesencumab (MNRP-1685A) is an IG1 antibody targeting NRP-1 with anti-angiogenic and anti-tumor activity that reduces the number of globules formed by the SUM159 and Hs578T cell lines. Vesencumab inhibits EGFR and PDGFRα activation and can be used to study solid tumors.
-
Ravulizumab
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity, targeting complement factor 5 to block complement activation.
-
C3a 70-77 2TFA(63555...
C3a 70-77 2TFA is an octapeptide corresponding to the COOH terminus of C3a.
